EUVIMEDEUVIMED entdecken
Crossref

Cancer Risks of Patients with Graves’ Disease Who Received Antithyroid Drugs as Initial Treatment: A Nationwide Population-Based Analysis

Ju-Yeun Lee, Min Kyung Lee, Jae Hyuk Lee, Kyungsik Kim iD, Kunho Bae, Seo Young Sohn iD

Thyroid® · 2024

DOI: 10.1089/thy.2024.0178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thyroid®, 2024. Verfasst von Ju-Yeun Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Myongji Hospital, Hanyang University College of Medicine, Goyang, South Korea. Hauptthemen laut MEDLINE: Graves Disease, Antithyroid Agents, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graves DiseaseAntithyroid AgentsNeoplasmsHumansMaleFemaleMiddle AgedRepublic of KoreaAdultRetrospective StudiesAgedIncidenceThyroid NeoplasmsRisk FactorsYoung AdultProportional Hazards ModelsDatabases, Factual

Stichwörter der Autor:innen

Graves’ diseasecancer riskcohort studyhyperthyroidism

Substanzen

Antithyroid Agents

Autor:innen und Institutionen

  • Department of Ophthalmology, Myongji Hospital, Hanyang University College of Medicine, Goyang, South Korea.
  • Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea.
  • Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, South Korea.
  • Division of Endocrinology, Department of Internal Medicine, Myongji Hospital, Hanyang University College of Medicine, Goyang, South Korea.
  • Cancer Research Institute, Seoul National University, Seoul, Korea.
  • Department of Ophthalmology, Seoul National University Hospital, Seoul, South Korea.

ORCID-Profile: Kyungsik Kim, Seo Young Sohn

Zitieren

APA

Lee, J. Y., Lee, M. K., Lee, J. H., Kim, K., Bae, K., & Sohn, S. Y. (2024). Cancer Risks of Patients with Graves’ Disease Who Received Antithyroid Drugs as Initial Treatment: A Nationwide Population-Based Analysis. Thyroid®. https://doi.org/10.1089/thy.2024.0178

Vancouver

Lee JY, Lee MK, Lee JH, Kim K, Bae K, Sohn SY. Cancer Risks of Patients with Graves’ Disease Who Received Antithyroid Drugs as Initial Treatment: A Nationwide Population-Based Analysis. Thyroid®. 2024. doi:10.1089/thy.2024.0178

BibTeX
@article{Lee2024,
  author = {Lee, Ju-Yeun and Lee, Min Kyung and Lee, Jae Hyuk and Kim, Kyungsik and Bae, Kunho and Sohn, Seo Young},
  title = {Cancer Risks of Patients with Graves’ Disease Who Received Antithyroid Drugs as Initial Treatment: A Nationwide Population-Based Analysis},
  journal = {Thyroid®},
  year = {2024},
  doi = {10.1089/thy.2024.0178}
}
Kostenlos starten →